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C
ancer cells become far more dangerous 
when they gain the ability to metastasize 
and colonize other parts of the body. But 
to start moving, the rogue cells have to break away 
from their neighbors. Walter Birchmeier (now at 
the Max-Delbrück-Center of Molecular Medicine in 
Berlin, Germany) and colleagues discovered how, 
showing that some cancer cells down-regulate a 
surface receptor that locks adjacent cells together.
The protein, known as E-cadherin, had 
caught the eye of developmental biologists such 
as Francois Jacob and Gerald Edelman because it 
enables the early embryo to keep its shape, Birch-
meier recalls. His group tested whether E-cadherin 
(previously known as uvomorulin) altered the sticki-
ness of dog kidney epithelial cells. In culture, the 
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ake away their supply of nerve 
growth factor (NGF), and neurons 
lose the will to live. In 1988, the 
conventional wisdom held that the cells 
wasted away because NGF helped keep 
metabolism churning. After all, NGF is 
a trophic factor, meaning that it literally 
“nourishes” the cell. But neuroscientist 
Eugene Johnson (Washington University, 
St. Louis) and colleagues suspected that 
the molecule instead prevented neurons 
from committing suicide—a controver-
sial assertion that they confi  rmed  with 
some simple experiments. The issue was 
important, Johnson says, because droves 
of surplus neurons perish during develop-
ment, and uncovering the requirements for 
cell survival might clarify how this attri-
tion helps wire the nervous system. The 
knowledge might also reveal measures for 
sparing neurons jeopardized by stroke and 
neurodegenerative diseases.
Johnson and colleagues reasoned that if 
NGF were essential for metabolism, shut-
ting down protein or messenger RNA syn-
thesis would speed the cells’ demise. But if 
NGF stalled a cell-killing mechanism that 
required fresh mRNA and proteins, halting 
their production would delay death. To test 
their hypothesis, the researchers cultured 
neurons and then added antibodies that neu-
tralized the NGF (Martin et al., 1988). After 
about a day of deprivation, the cells started 
to shrink and their membranes began to 
seethe. The medium showed a surge in ade-
nylate kinase, a protein normally confi  ned to 
the cytoplasm, demonstrating that the neu-
rons were spilling their guts. But a dose of 
cycloheximide, a protein synthesis inhibitor, 
proved to be a balm for the neurons. “Cells 
without cycloheximide were toast, and cells 
with cycloheximide were beautiful,” recalls 
Johnson. Moreover, little adenylate cyclase 
leaked from treated cells, further evidence 
that they remained whole. Treating NGF-de-
prived cultures with actinomycin-D, an RNA 
synthesis blocker, also derailed cell death. 
The results “changed how people thought 
about what trophic factors do and how cells 
die,” says Johnson. Neurons weren’t pining 
away; they were killing themselves.
Although other researchers had per-
formed similar experiments, their results 
had been unclear, Johnson recalls. His 
group, however, made a fortunate choice. 
Other workers had studied neurons that re-
quired a constant supply of new proteins, 
and the cells died swiftly after translation 
or transcription halted. But the sympathetic 
neurons Johnson and colleagues examined 
could endure a four-day hiatus from pro-
tein making, possibly 
because they were post-
mitotic. His group went 
on to map the sequence 
of events in a neuron’s 
death, showing that the 
cell-slaying program 
eventually reaches 
a point of no return 
(Deckwerth and Martin, 
1993). The invention 
of PCR allowed his lab 
to identify some of the 
genes that orchestrate 
neuron suicide (Estus et 
al., 1994).  ML
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cube-shaped cells normally pack closely together and resemble a cobblestone 
street. Adding an antibody that latches onto E-cadherin spurred the cells to break 
up and take on a ragged, irregular shape (Behrens et al., 1989). Moreover, the 
cells could inﬁ  ltrate a layer of collagen and burrow into chunks of chick heart, 
signs that they had severed their moorings and become invasive. The researchers 
then infected normal dog kidney cells with an oncogene-carrying virus and saw 
the same transformation—the cells dispersed and began traveling. The notion 
that pro-growth oncogenes could promote cancer was familiar at the time, Birch-
meier says, but “the idea that you lose something 
to become invasive was relatively new.” The work 
also demonstrated that cells could become invasive 
even if they weren’t cancerous.
In a follow-up study, Birchmeier’s group 
linked E-cadherin to human cancers (Frixen et al., 
1991). They analyzed cell lines from many differ-
ent carcinomas—epithelial tumors that are the most 
prevalent type of cancer in humans—and found 
that the invasive lines lacked E-cadherin. What’s 
more, reinstalling the gene for E-cadherin reigned 
in the cells’ wanderlust. Birchmeier and colleagues 
later discovered that an oncogene called v-src 
didn’t alter the expression of E-cadherin. However, 
it did increase the number of phosphate groups 
stuck to E-cadherin and the bridging protein 
β-catenin, which connects E-cadherin to the cyto-
skeleton (Behrens et al., 1993). These results re-
vealed that it's possible to reduce cell stickiness 
not only by reducing the amount of E-cadherin but 
also by altering the protein's structure. ML
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Neurons without NGF die 
off (top) unless cyclohexi-
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